Details for New Drug Application (NDA): 202271
✉ Email this page to a colleague
The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acarbose profile page.
Summary for 202271
Tradename: | ACARBOSE |
Applicant: | Avet Lifesciences |
Ingredient: | acarbose |
Patents: | 0 |
Pharmacology for NDA: 202271
Mechanism of Action | alpha Glucosidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 202271
Suppliers and Packaging for NDA: 202271
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACARBOSE | acarbose | TABLET;ORAL | 202271 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-147 | 23155-147-01 | 100 TABLET in 1 BOTTLE (23155-147-01) |
ACARBOSE | acarbose | TABLET;ORAL | 202271 | ANDA | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-147 | 23155-147-05 | 500 TABLET in 1 BOTTLE (23155-147-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Feb 7, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Feb 7, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 7, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription